Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective

• Main Authors: Ricardo Mesquita Camelo (Author), Mariana Michel Barbosa (Author), Luila Clicia Moura Henriques (Author), Antony Paul Martin (Author), Brian Godman (Author), Augusto Afonso Guerra Júnior (Author), Francisco de Assis Acurcio (Author), Juliana Alvares-Teodoro (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Costs of hemophilia A treatment are increasing. Waste of clotting products should be avoided. To estimate the first-year waste of emicizumab prophylaxis for people with hemophilia A and inhibitors (PwHAi) who failed immune tolerance induction (ITI), in Brazil. We evaluated the manufacturer and the B...